NCT05744713
An Observational Study of Patients With Chronic Liver Disease
Enrolling by Invitation
Not specifiedAges 18+ObservationalTarget PharmaSolutions, Inc.
~500,000 participants
Updated 2026-03-03 on ClinicalTrials.gov
What's tested:Observational
At a glance
Recruiting sites
0 of 10 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To characterize the natural history of disease in patients with CLD from various etiologies and Cirrhosis
Measured over 20 Years
+2 more outcomes measured
Conditions
Where it's being run
10 sites across 7 statesCalifornia2
Pennsylvania2
Texas2
District of Columbia1
Illinois1
New York1
North Carolina1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adult\* patients diagnosed and managed for CLD/cirrhosis invited to participate
Ability to provide written informed consent
Exclusion
Death
Manual removal (sponsor or site request)
No EHR interface encounter \> 3 years.
Patient expressed desire to withdraw consent to complete PROs
Failure to complete PROs within 24 weeks of initial invitation
Greater than 24 months lapse of survey completion after baseline surveys completed
Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort.
What this trial measures
- To characterize the natural history of disease in patients with CLD from various etiologies and Cirrhosis20 Years
- To assess safety and effectiveness of CLD/Cirrhosis treatments and treatments for complications of any chronic liver disease20 Years
- To establish learning health networks focused on quality of care for patients20 Years